Predict your next investment

Venture Capital

See what CB Insights has to offer

Investments

9

Portfolio Exits

1

About Scandinavian Life Science Venture

Scandinavian Life Science Venture Headquarter Location

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing Scandinavian Life Science Venture

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Find Scandinavian Life Science Venture in 1 Expert Collection, including Pharma Startups.

P

Pharma Startups

5,090 items

Pharmaceutical companies working across drug discovery, drug development and drug manufacturing.

Scandinavian Life Science Venture Investments

9 Investments

Scandinavian Life Science Venture has made 9 investments. Their latest investment was in Light Sciences Oncology as part of their Series C on July 7, 2008.

CBI Logo

Scandinavian Life Science Venture Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

7/17/2008

Series C

Light Sciences Oncology

$40.1M

No

6/30/2007

Unattributed VC

Subscribe to see more

$99M

Subscribe to see more

10

1/16/2006

Series D

Subscribe to see more

$99M

Subscribe to see more

10

12/7/2005

Series A

Subscribe to see more

$99M

Subscribe to see more

10

5/20/2005

Series A

Subscribe to see more

$99M

Subscribe to see more

10

Date

7/17/2008

6/30/2007

1/16/2006

12/7/2005

5/20/2005

Round

Series C

Unattributed VC

Series D

Series A

Series A

Company

Light Sciences Oncology

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Amount

$40.1M

$99M

$99M

$99M

$99M

New?

No

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

10

10

10

10

Scandinavian Life Science Venture Portfolio Exits

1 Portfolio Exit

Scandinavian Life Science Venture has 1 portfolio exit. Their latest portfolio exit was Symphogen on April 03, 2020.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

4/3/2020

Acquired

11

Date

4/3/2020

Exit

Acquired

Companies

Valuation

Acquirer

Sources

11

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.